A MedAlliance FDA Clinical Trial
in Below-the-Knee arteries

The aim of the SELUTION4BTK clinical trial is to demonstrate the superior efficacy and equivalent safety of SELUTION SLR™ compared to plain (uncoated) balloon angioplasty (POBA) in the treatment of BTK (Below-the-Knee) arteries in Chronic Limb Threatening Ischemia (CLTI) patients. The trial is a prospective, multi-center, single blinded, randomized study.